RegenaLife

What RegenaLife does

RegenaLife is a Canadian longevity medicine company founded in 2023 and headquartered in Niagara Falls, Ontario, that sells AI-enabled early-disease-detection screening and optimization services to affluent individuals, senior executives with executive medical benefits, and corporate employees covered by participating group health plans. Its product architecture centers on the MedAdvance family — Big 3 Baseline, Cancer, Heart, Brain, and Complete — which bundle AI-interpreted full-body and brain MRI, Coronary CT Angiography (CCTA), multi-cancer blood detection (50+ cancer types), whole genome sequencing (350,000+ mutation-to-phenotype associations), biological age assessment via methylation markers and telomere length, executive blood panels, cellular micronutrient analysis, and bone density / body composition scans, followed by an Optimization layer of IV therapy, pharmaceutical interventions, nutraceuticals, and health-coach-led lifestyle programs. The company monetizes via a $447 Health Risk Assessment entry product (credited toward higher tiers), quote-based premium MedAdvance packages sold D2C through phone and website, and insurance reimbursement under Best Doctors Canada and VUMI Canada group health plans. RegenaLife goes to market through direct sales, a website storefront with Calendly-driven consultations, content marketing and organic social channels, and B2B2C distribution via its insurance carrier partners, while leveraging cross-border US and European healthcare center alliances to extend treatment access beyond Canada.

Name

RegenaLife

Legal name

Regenalife

Website

https://regenalife.ca

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

RegenaLife is a Canadian longevity medicine company that sells AI-enabled MedAdvance screening packages — including AI-interpreted MRI, CCTA, multi-cancer blood testing, whole genome sequencing, and biological age assessment — to affluent consumers, senior executives, and insurance-covered corporate employees.

Ownership category

akta.pro rank

Product category

Longevity Medicine / Preventive Health Screening

SIC

Services-Health Services (8000), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

akta.pro secondary industries

Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG), Prognostic & Risk Stratification Biomarkers (disease progression, recurrence risk) (HLAAAMAF)

Keywords

• Longevity medicine
• Early disease detection
• Functional medicine
• AI diagnostic imaging
• Preventive health screening

Headquarters

HQ city

Niagara Falls

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. MedAdvance Screening Packages: Comprehensive AI-enabled health screening packages (Big 3 Baseline, Cancer, Heart, Brain, and Complete) providing early detection services. Packages include MRI, CT angiography, cancer screening, genome sequencing, blood panels, and consultation. Revenue generated through one-time purchase of screening programs.
2. Health Risk Assessment: Entry-level assessment at $447 including comprehensive health questionnaire, executive blood work panel, AI-enhanced analysis, and practitioner consultation. Fee credited toward advanced screening packages if customer proceeds, serving as a conversion mechanism.
3. Insurance-Reimbursed Services: Services covered under VUMI Canada Insurance and Best Doctors Canada Insurance group health plans, enabling revenue from insurance reimbursements for qualifying members.
4. MedAdvance Optimization / Therapy: Therapeutic treatments including lifestyle programs managed by health coaches, pharmaceutical interventions, IV therapy, nutraceuticals, and personalized treatment plans for longevity optimization.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

RegenaLife provides AI-enabled longevity medicine through its MedAdvance screening packages that use convolutional neural networks for presymptomatic detection of over 50 cancer types, cardiovascular disease via coronary CT angiography, and neurological disorders including Alzheimer's via brain MRI analysis. The company also offers MedAdvance Optimization therapeutics including lifestyle programs, IV therapy, pharmaceutical interventions, and personalized treatment plans, alongside whole genome sequencing and biological age assessment. An entry-level Health Risk Assessment ($447) serves as a conversion mechanism to higher-tier comprehensive screening programs.

Product overview

RegenaLife offers a comprehensive AI-enabled longevity medicine platform centered on MedAdvance packages for early disease detection and optimization. The product architecture consists of four core MedAdvance screening tiers (Big 3 Baseline, Cancer, Heart, Brain) combined in the MedAdvance Complete package, supported by individual diagnostic scans including Full-Body MRI, Coronary CT Angiography, Whole Genome Sequencing, Biological Age Assessment, Executive Blood Panel, Micronutrient Analysis, and Bone Density scans. The Health Risk Assessment serves as an entry-level assessment that can lead to higher-tier MedAdvance packages. MedAdvance Optimization provides therapeutic treatments including IV therapy, pharmaceutical interventions, and lifestyle programs. All screening services are powered by AI technologies including CNNs for medical imaging analysis and machine learning for genomic/methylation data interpretation.

Differentiator

Problem solved

Functional benefit

Brands

• MedAdvance: AI-enabled functional medicine and screening packages for early detection of cancers, cardiovascular and neurological disorders, including Big 3 Baseline, Cancer, Heart, Brain, and Complete packages.

Products and services

• MedAdvance Complete Comprehensive AI-enabled screening program that combines the Big 3 Baseline, Cancer, Heart, and Brain packages into a single holistic program designed for individuals seeking the most thorough disease detection and longevity optimization, addressing cancers, cardiovascular disease, and neurological disorders with quote-based pricing.
• MedAdvance Cancer AI-enhanced cancer screening service detecting over 50 types of cancer at stages 0 to 1 via blood test analysis, designed for individuals with a history of cancer or risk factors seeking presymptomatic detection before metastasis occurs.
• MedAdvance Heart AI-powered cardiac assessment using Coronary CT Angiography (CCTA) to detect artery narrowing and early soft plaque formation that can lead to cardiovascular disease, heart attacks, strokes, heart failure, and dementia, designed for individuals with cardiac risk factors or adults over 40 seeking proactive cardiac assessment.
• MedAdvance Brain AI-enhanced brain MRI screening service using proprietary AI assessment to detect lesions, gross brain region changes, and conditions associated with Alzheimer's disease, frontotemporal dementia, multiple sclerosis, epilepsy, and traumatic brain injury, designed for individuals seeking presymptomatic detection of neurodegenerative conditions.
• RegenaLife Big 3 Baseline AI-enhanced baseline assessment focusing on key tests to detect earliest signs of cancer, cardiovascular disease, and neurocognitive conditions (Alzheimer's, Dementia, Parkinson's), with recommendations for further testing based on findings. Designed as an entry-level screening program for individuals seeking initial proactive health assessment.
• Health Risk Assessment $447 entry-level comprehensive health assessment including an in-depth health and lifestyle questionnaire, executive blood work panel, AI-enhanced analysis, and practitioner consultation, with the fee credited toward further RegenaLife screening programs as a conversion mechanism.
• MedAdvance Optimization Therapeutic treatment program including lifestyle, exercise, and diet programs managed by health coaches, innovative health procedures, pharmaceutical interventions, IV therapy, hormone therapy, and customized supplements designed to improve longevity, healthspan, and quality of life based on screening findings.
• Full-Body and Brain MRI with AI High-resolution, non-invasive MRI scan without radiation exposure with AI-enhanced assessment identifying structural abnormalities including tumors, tissue changes, blood vessel issues, organ conditions, joint degeneration, and brain conditions including lesions, Alzheimer's-associated changes, frontotemporal dementia, MS, epilepsy, and traumatic brain injury.
• Coronary CT Angiography with AI AI-analyzed Coronary CT Angiography (CCTA) imaging service enabling presymptomatic detection of artery narrowing and early soft plaque formation, allowing preventative measures including lifestyle modifications and nutraceuticals before heart attacks, strokes, heart failure, or dementia occur.
• Early Cancer Detection Blood Test AI-enhanced blood test detecting over 50 types of cancer from a standard blood sample, including 45+ cancer types (pancreatic, thyroid, etc.) that lack routine screening tools, enabling early detection at stages 0 to 1 before metastasis when clinical treatments are most effective.
• Whole Genome Sequencing Deep DNA analysis enabling current and future assessment of potential health concerns through analysis of over 350,000 associations between genomic mutations and health-related findings, using evolving computer algorithms linking gene variations to genome-wide association studies.
• Biological Age Assessment Methylation marker and telomere length analysis providing biological age assessment relative to chronological age via machine learning algorithm analyzing approximately 1 million DNA locations for health outcome correlations, enabling more accurate healthspan and lifespan prediction than any other single analysis.
• Executive Blood Panel Comprehensive bloodwork assessing kidney and liver function, vitamin and mineral levels, hormone levels, lipid status, glucose/insulin markers, inflammatory markers, and other key biological indicators as part of the broader health screening portfolio.
• Micronutrient Analysis Comprehensive nutritional analysis measuring functional nutrient deficiencies at the cellular level across 31 vitamins, minerals, amino/fatty acids, antioxidants, and metabolites, providing a 4-6 month functional picture unlike standard serum measurements and assessing how well the body utilizes nutrients.
• Bone Density & Body Composition Scan REMS scan calculating mineral content for bone strength assessment, muscle mass, and body fat composition, enabling tracking of bone health changes over time and monitoring treatment efficacy for osteoporosis.

Quantifiable outcome

• Detection of over 50 cancer types, including 45 currently lacking routine screening
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• VUMI Canada InsurancecoreGTM or Marketing Partner · 30 June 2026VUMI Canada Insurance provides coverage for RegenaLife services through its group health insurance plans, making RegenaLife the second international insurance carrier to fund the company’s early detection and precision-based healthcare approach. Members enrolled in qualifying VUMI Canada group health plans can access RegenaLife services as part of their existing benefits, expanding reach across Southern Ontario and beyond.
• Best Doctors Canada Insurance ServicescoreGTM or Marketing PartnerBest Doctors Canada Insurance Services was the first international health insurance carrier to recognize and fund RegenaLife’s approach to proactive, early detection and precision-based healthcare, preceding VUMI Canada as the initial insurance partner.
• Cross-border US Healthcare PartnerscoreStrategic or Co-development PartnerRegenaLife has aligned with cross-border US partners to make MedAdvance packages available in local markets across the world for the first time. These partnerships enable access to breakthrough AI-enabled longevity medicine technologies and functional medicine practitioner expertise concentrated in the US.
• European Healthcare CentersminorStrategic or Co-development PartnerREGENALIFE is partnered with multiple healthcare centers in the US and Europe to provide a comprehensive portfolio of treatments on a timely basis, extending service capabilities beyond Canadian operations.

Scale indicators2 records

Recent moves6 records

Direct peers

• Forward Health: Forward operates a tech-forward preventive primary care membership including full-body diagnostics, AI-driven risk scoring, and longevity-focused care—an adjacent but materially overlapping consumer model with similar AI/diagnostic positioning.
• Parsley Health: Parsley Health is a functional medicine membership practice combining advanced diagnostics, holistic care plans, and practitioner-led coaching—directly comparable to RegenaLife's functional/regenerative medicine arm and MedAdvance Optimization service.
• InsideTracker: InsideTracker provides AI-informed analysis of blood biomarkers, DNA, and lifestyle data for personalized longevity and performance recommendations, directly overlapping RegenaLife's biological age, micronutrient, and genomic products.
• Human Longevity Inc. HLI delivers whole-genome sequencing combined with advanced imaging and AI-driven risk assessment for affluent longevity-focused clients, mirroring RegenaLife's combination of WGS, MRI, and AI biomarker analytics.
• Function Health: Function Health offers comprehensive blood-based biomarker testing and AI-driven health insights through a membership model aimed at proactive, consumer-driven preventive health—a directly comparable offering to RegenaLife's biomarker and biological age testing stack.
• Fountain Life: Fountain Life operates AI-enabled preventive health and longevity centers offering full-body MRI, CCTA, and early-disease screening in a concierge model—directly comparable to RegenaLife's MedAdvance platform in product, customer, and AI positioning.
• EZRA: EZRA offers AI-assisted full-body MRI screening for early cancer and disease detection on a consumer-pay basis—closely matching RegenaLife's MedAdvance Cancer and MedAdvance Complete imaging packages.

Broad incumbents

• Mayo Clinic Executive Wellness Program: Mayo Clinic's Executive Wellness Program delivers integrated preventive diagnostics and personalized plans for executives—a broad incumbent comparable to RegenaLife's premium screening and optimization bundles.
• Cleveland Clinic Executive Health: Cleveland Clinic's Executive Health program offers comprehensive preventive screening and concierge physician access to senior executives—overlapping RegenaLife's primary target segment of executives with executive benefit packages.

Emerging players

• TruDiagnostic: TruDiagnostic specializes in epigenetic biological age testing via methylation analysis—overlapping the biological age assessment feature in RegenaLife's diagnostic suite, though narrower in disease-screening scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/regenalife
• Instagraminstagram.com/regenalife
• LinkedInlinkedin.com/company/regenalife-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RegenaLife